Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.7410
-0.0041 (-0.55%)
At close: Jul 2, 2026, 4:00 PM EDT
0.7844
+0.0434 (5.86%)
After-hours: Jul 2, 2026, 5:42 PM EDT
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.18 million as of July 2, 2026. Its market cap has decreased by -6.81% in one year.
Market Cap
9.18M
Enterprise Value
-37.29M
1-Year Change
-6.81%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.18M, a decrease of -51.54%. That is a compound annual growth rate of -16.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 9.18M | 53.81% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 10.33M |
| Vistagen Therapeutics | 10.21M |
| BioRestorative Therapies | 10.19M |
| Jupiter Neurosciences | 9.68M |
| Can-Fite BioPharma | 9.27M |
| Quoin Pharmaceuticals | 9.20M |
| TransCode Therapeutics | 8.18M |
| Aspire Biopharma Holdings | 8.04M |